欢迎光临金融市场技术研究院
微信公众号
投资群
读书群
文章
  • 文章
  • 报告
  • 图书
  • 公募
  • 私募
  • 资讯
搜 索
上传文档
首页 文章 报告 图书 公募 私募 资讯
金融终端
您的当前位置：首页 > 研究报告 > 外盘报告 > 预览报告
Continue to pursue the development of proxalutamide for treatment of COVID-19
报告类型：港股公司研究 页数：5 文件大小：869K 上传时间：2024-09-20
机构：招银国际 作者：Jill Wu Andy Wang 43阅读 0收藏 0下载
下载PDF
下载全文所需积分：1
网友评论
{{Creator}}
{{Body}}
{{$val.TimeAgo({Dtime})}} [回复]
{{Creator}}： 回复 {{BeQuote}}
{{Body}}
{{$val.TimeAgo({Dtime})}} [回复]
上传用户
相关报告
每日港股简评 An attractive entry point of a cash cow 每日港股简评 Core emphasis on provision of high quality medical services 每日港股简评 Exploration of new income stream Set to deliver strong earnings recovery in 2022E; U/G to BUY Our read on its termination of first service acquisition and latest operation update 每日港股简评 Termination of Coverage
mtachn.com
© 2013 mtachn,. All Rights Reserved.
苏ICP备48665885号-3
关于我们
学会宗旨 培训考试 联系方式
资源投稿
积分规则 投搞协议 评审标准
合作伙伴
微信公众号
{"InnerBanner":null,"MbPageUrl":"/m/Datums/Report?id=5763337","PageTitle":"Continue to pursue the development of proxalutamide for treatment of COVID-19-外盘报告 - 研究报告","Redirect":null,"Data":{"Uploader":{"ID":72,"Face":"/_files/face/0/ip66x93g.jpg","UName":"旅锐精","UpArts":0,"UpRpts":24107,"UpLbies":20},"Rid":5763337,"IsPdf":false,"IsExist":false,"PdfUrl":"/download2.mtachn.com/upload/report/外盘报告/20211229-招银国际-开拓药业-B-09939.HK-Continuetopursuethedevelopmentofproxalutamidefortreatme","RePage":-1},"UserInfo":{"ID":0,"UName":null,"Face":null}}